Correlation between duration of first-line treatment with daratumumab, lenalidomide, and dexamethasone and overall survival in patients with transplant-ineligible multiple myeloma in Japan

Correlation between duration of first-line treatment with daratumumab, lenalidomide, and dexamethasone and overall survival in patients with transplant-ineligible multiple myeloma in Japan

<p>Optimal management of multiple myeloma (MM) remains challenging, particularly among patients with transplant-ineligible newly diagnosed MM (TIE NDMM). Daratumumab + lenalidomide + dexamethasone (DRd) is approved in Japan for the treatment of TIE NDMM. A previously reported real-world, retro...

Saved in:

書目詳細資料
主要作者:	Kazuhito Suzuki (22688384) (author)
其他作者:	Miku Ito (22688387) (author), Chika Sakai (5712761) (author), Hiroaki Tsuchiya (2437369) (author), David Bin-Chia Wu (7251623) (author), Yosuke Koroki (12979839) (author)
出版:	2025
主題:	Medicine Pharmacology Biotechnology Immunology Cancer Science Policy Mental Health Daratumumab duration of treatment lenalidomide newly diagnosed multiple myeloma overall survival real-world evidence
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Table 1_Comparison of self-reported sleep sufficiency and accelerometer-measured sleep duration in relation to mental health, physical health, and life satisfaction.docx
由: Hannah Ahrensberg (22686239)
出版: (2025)

Table 1_Clinical study on the effects of different cold compress methods and durations on postoperative complications following mandibular impacted third molar extraction.docx
由: Zhiwen Xie (6335777)
出版: (2025)

Data Sheet 1_Impact of individualized and structured aerobic exercise on clinical outcomes in pediatric congenital heart diseases with post-surgical rehabilitation: a meta-analysis.docx
由: Ayoola Awosika (22687004)
出版: (2025)

DENV and CHIKV IgG serology and RT-PCR test results among overall study population and individual study sites Ukunda and Kisumu, Kenya, Dec 2019–Feb 2022.
由: Bethel Alebel Bayrau (22676588)
出版: (2025)

Overall acceptability of the MNH-EPI-COS.
由: Karen Klein (6650600)
出版: (2025)

The MBM-Index as an independent predictor of overall survival (OS) in melanoma.
由: Jingxin Zeng (18773484)
出版: (2025)

Participant characteristics in the overall cohort and in groups classified by dysmenorrhea score.
由: Maika Nariai (22676447)
出版: (2025)

Supplementary Table S1 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma
由: Phyllis S.Y. Chong (17141520)
出版: (2025)

Supplementary Table S2 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma
由: Phyllis S.Y. Chong (17141520)
出版: (2025)

Kaplan-Meier curves of (A) progression-free survival and (B) overall survival.
由: Lu Xie (20428615)
出版: (2025)

Reducing Anxiety and Improving Adherence in Kidney Transplant Recipients: A Cognitive Behavioral Intervention -Based Approach
由: Chao Zhong (22679885)
出版: (2025)

Short periods of increased connectivity between ROIs are characterized by a sparse overall network state.
由: Adam J. O. Dede (11554007)
出版: (2025)

Data Sheet 1_Glycocalyx kinetics and injury during liver procurement and transplantation as predictors of early graft dysfunction.docx
由: Nassiba Beghdadi (9577919)
出版: (2025)

Additional file 3 of Trends in national-level school feeding policy objectives worldwide: Japan and multiple countries
由: Takeshi Akiyama (4825470)
出版: (2025)

Additional file 2 of Trends in national-level school feeding policy objectives worldwide: Japan and multiple countries
由: Takeshi Akiyama (4825470)
出版: (2025)

Presynaptic and postsynaptic weights change monotonically linearly over stimulus duration.
由: Nicholas Hananeia (22683665)
出版: (2025)

A linear regression analysis was conducted between the overall performance in the visual selective attention task (accuracy and reaction time) and the CISS score.
由: Mohammed M. Alnawmasi (11156577)
出版: (2025)

Investigation on the Occurrence of Premature Ovarian Insufficiency after Allogeneic Haematopoietic Stem Cell Transplantation and Prognosis Analysis - a single-center real-world cross-sectional study
由: 辰宇石 (22420348)
出版: (2025)

Hematocrit levels.
由: Ömer Yusuf İpek (22676357)
出版: (2025)

Morris water maze spatial patterns.
由: Ömer Yusuf İpek (22676357)
出版: (2025)

Morris water maze swim paths.
由: Ömer Yusuf İpek (22676357)
出版: (2025)

Morris water maze performance during the probe trial (Day 5).
由: Ömer Yusuf İpek (22676357)
出版: (2025)

Morris water maze performance across acquisition and reversal phases.
由: Ömer Yusuf İpek (22676357)
出版: (2025)

Three-chamber test spatial patterns.
由: Ömer Yusuf İpek (22676357)
出版: (2025)

Three-chamber test behavioral outcomes.
由: Ömer Yusuf İpek (22676357)
出版: (2025)

Experimental design.
由: Ömer Yusuf İpek (22676357)
出版: (2025)

Hematological parameters statistical data.
由: Ömer Yusuf İpek (22676357)
出版: (2025)

Morris water maze test day based statistical data.
由: Ömer Yusuf İpek (22676357)
出版: (2025)

Morris water maze test progression statistical data.
由: Ömer Yusuf İpek (22676357)
出版: (2025)

Three chamber test statistical data.
由: Ömer Yusuf İpek (22676357)
出版: (2025)

Multivariate analysis between DENV and CHIKV seroconversion and selected risk factors.
由: Bethel Alebel Bayrau (22676588)
出版: (2025)

Univariate analysis between DENV and CHIKV seroconversion and selected risk factors.
由: Bethel Alebel Bayrau (22676588)
出版: (2025)

Multivariate analysis between DENV and CHIKV seropositivity and selected risk factors.
由: Bethel Alebel Bayrau (22676588)
出版: (2025)

Univariate analysis between DENV and CHIKV seropositivity and selected risk factors.
由: Bethel Alebel Bayrau (22676588)
出版: (2025)

Descriptive statistics and demographics of study participants, Ukunda and Kisumu sites, Kenya, Dec 2019–Feb 2022.
由: Bethel Alebel Bayrau (22676588)
出版: (2025)

Kaplan Meier survival curves for new DENV seropositivity during the 2-year study period from Dec 2019 – Feb 2022..
由: Bethel Alebel Bayrau (22676588)
出版: (2025)

Kaplan Meier survival curves for new CHIKV seropositivity during the 2- year study period from Dec 2019 – Feb 2022.
由: Bethel Alebel Bayrau (22676588)
出版: (2025)

Distribution of DENV and CHIKV seroprevalence by age group of participants in the study.
由: Bethel Alebel Bayrau (22676588)
出版: (2025)

Seroconversion of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022.
由: Bethel Alebel Bayrau (22676588)
出版: (2025)

Seroprevalence of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022.
由: Bethel Alebel Bayrau (22676588)
出版: (2025)

Cannot write session to /tmp/vufind_sessions/sess_oamf1nl5rim2bqrhdnugr9cm8p